Farmaco-epidemiologie
Novel methodologies for causal research with real world data
- Universiteit Rijksuniversiteit Groningen
- Promovendus Ali Alghamdi
- Promoters E. Hak
- Co-Promoters M.J. Bijlsma
- Jaar 2022-2026
KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn20resultaten gevonden
Farmaco-epidemiologie
Towards personalized primary prevention of cerebroand cardiovascular diseases: observational studies based on the real-world data of 167,000 participants in the Netherlands
- Universiteit Rijksuniversiteit Groningen
- Promovendus Xuechun Li
- Promoters E. Hak
- Co-Promoters S. Mubarik
- Jaar 2021-2025
Farmaco-epidemiologie
RCT or RWE? Investigating standards that RWE needs to meet to supplement evidence from RCTs - building a framework
- Universiteit Rijksuniversiteit Groningen
- Promovendus Stefan Verweij
- Promoters E. Hak P.G.M. Mol
- Co-Promoters M.J. Bijlsma K. Oude Rengerink
- Jaar 2022-2027
Farmaco-economie
Quality of life, frailty assessment, and pharmacoeconomics in the age of targeted therapies for acute myeloid leukemia
- Universiteit Rijksuniversiteit Groningen
- Promovendus Benno Diekmann
- Promoters E.N. van Roon
- Co-Promoters M. Hoogendoorn N.J.G.M. Veeger
- Jaar 2022-2026
Farmaco-epidemiologie
Estimating the scale of immunity gaps towards Measles and Rubella elimination: Case studies and epidemiological profile of Nigeria
- Universiteit Rijksuniversiteit Groningen
- Promovendus A.E. Jean Baptiste
- Promoters E. Hak E.A. Sanders
- Co-Promoters S.J.M. Hahne
- Jaar 2019-2022
Farmaco-economie
Optimization of the evaluation of oncology drugs for reimbursement
- Universiteit Rijksuniversiteit Groningen
- Promovendus Sharon Wolters
- Promoters M. Postma F.G.A. Jansman
- Jaar 2019-2025
The research focusses on several aspects related to reimbursement: factors influencing the time to reimbursement, measures to improve the time to reimbursement, differences in the clinical evidentiary requirements of oncology assessment, EMA versus HTA bodies and changes in economic evaluations of oncology drugs in time.
Farmaco-economie
Towards personalized and cost-effective care for depression
- Universiteit Rijksuniversiteit Groningen
- Promovendus Fang Li
- Promoters T.L. Feenstra
- Co-Promoters F. Jörg
- Jaar 2021-2025
The research project aims to develop models for the prediction of disease duration in order to support personalized and cost-effective care of depression patients. Using these models, optimal treatment strategies will be analyzed. In this project, we also want to predict treatment resistant depression as a specific subgroup and conduct cost-effectiveness analyses of different psychotherapy strategies and quantify the impact of structural uncertainty and parameter uncertainty on the results of cost-effectiveness evaluations.
Pagina 1 van 3